Image 1
Treprostinil Injection, Solution
Product Images NDC 0703-0686
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Treprostinil (NDC 0703-0686). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Parenteral Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
This is a product label for an injection called Treprostinil. It is available in a 50 mg/20 mL (2.5 mg/mL) multiple dose vial for subcutaneous or intravenous infusion. The medication must be diluted with sterile water or other sterile diluent before use. It has a recommended dosage that should be seen in the package insert. Treprostinil is a registered trademark of Teva Pharmaceuticals USA and is manufactured in Croatia by Pliva Hrvatska doo. There is also a coding area on the label.*
Image 5
This is a description of Treprostinil Injection, a medication in a 100mg/20mL (5mg/mL) multipledose vial that is used for subcutaneous or intravenous infusion only. It contains treprostinil, sodium citrate, sodium chloride, metacrso, sodium hydrosids, and Water for Injection. Before being administered through intravenous infusion, the medicine must be diluted with Sterile Water for Injection, 0.9% Sodium Chloride Injection, Sterile Diluent for Remodulin, Sterile Diluent for Flolan, or Sterile Diluent for Epoprostenol Sodium. Dosage directions can be found in the package insert. The medicine is manufactured in Croatia by Piva Hratska 400, Zagreb and is made for Teva Pharmaceuticals USA, Horth Wales, PA 19454. It should be stored between 2°C to 30°C (36° 1 to 86°F) with excursions permitted to 25°C (17°F). This medicine is only available with a prescription.*
Image 6
Treprostinil Injection is a medication available in a 200mg/20 mL presentation, contained in a 20 mL multiple-dose vial. The medicine is indicated for subcutaneous or intravenous infusion only, to dilate blood vessels and ease the workload of the heart in certain conditions. Before intravenous infusion, it must be diluted with sterile water or other indicated diluents. The usual dosage is displayed on the package insert included with the product. It should be stored between 25°C (17°F) excursions permitted 10 210 30°C (36° to 86°F) and kept out of the reach of children. The medicine is manufactured by Piva Hivatska in Zagreb, Croatia, and distributed by Teva Pharmaceuticals USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
